Gintarė Lukoševičiūtė
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gintarė Lukoševičiūtė has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Jintian Huang
Department of Clinical Sciences Lund, Orthopedics, Lund University, 221 84 Lund, Sweden
2 shared publications Alfredas Smailys
1 shared publicationAugustinas Rimkunas
Department of Orthopedics and Traumatology, Hospital of Lithuanian University of Health Sciences (LSMU), Kaunas Clinics, Kaunas, Lithuania
1 shared publicationAurelijus Domeika
Institute of Mechatronics, Kaunas University of Technology, Kaunas, Lithuania
1 shared publication- Aurimas Sirka
Department of Orthopedics, Kaunas Hospital of the Lithuanian University of Health Sciences, Kaunas, Lithuania
1 shared publication Benny Dahl
1 shared publication
Latest Publications
- Open Access
- 6 October 2026
- Published by Elsevier in North American Spine Society Journal (NASSJ)
- Vol. 28
Evaluation of a pre-set calcium sulphate dihydrate/hydroxyapatite bone graft extender in a rabbit posterolateral spinal fusion model
- 6 October 2026
- Published by Elsevier in North American Spine Society Journal (NASSJ)
- Vol. 28
Open AccessEvaluation of a pre-set calcium sulphate dihydrate/hydroxyapatite bone graft extender in a rabbit posterolateral spinal fusion model
- Open Access
- 1 March 2026
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 17 (3) , 118
A Pre-Set Calcium Sulfate/Hydroxyapatite Biomaterial as an Antibiotic-Eluting Bone Extender and a Carrier for BMP-2: A Pilot Study in a Rabbit Posterolateral Spinal Fusion Model
Synthetic biomaterials used as bone graft extenders (BGE) in spinal fusion surgery can supplement but do not replace autologous bone. This pilot study evaluated a calcium sulfate/hydroxyapatite (CaS/HA) material as an antibiotic-eluting BGE and a carrier for bone morphogenetic protein-2 (BMP-2) in a rabbit posterolateral lumbar (L4–L5) spinal fusion model (PLF). Pre-set CaS/HA beads were loaded with tobramycin (TOB) and tested for in vitro antibiotic release and antibacterial activity against Staphylococcus aureus. For the in vivo PLF study, CaS/HA beads were used in two treatment strategies: (1) CaS/HA + TOB + autograft (left side) and (2) CaS/HA + BMP-2 (right side). Serum levels of TOB were quantified and spinal fusion was evaluated after 12 weeks. TOB exhibited a rapid initial release, followed by a decline below detectable levels after 6 h in vitro and 48 h in vivo. TOB-loaded CaS/HA beads demonstrated in vitro antibacterial activity for 19 days. In the PLF study, 5/6 and 6/6 specimens were fused radiologically in the TOB and BMP groups, respectively, and 100% using mechanical testing. Micro-CT analysis showed no significant difference in bone volume between the TOB and BMP-2 groups (364 ± 84 vs. 479 ± 95 mm3). Histology verified continuous bone bridging in both groups. Our in vitro findings indicate that locally added TOB could protect the CaS/HA material from bacterial colonization and did not adversely impact the CaS/HA material negatively to act as BGE. The addition of low-dose BMP-2 to the CaS/HA material proved effective in building bone without the need to harvest autologous bone. In summary, this pilot PLF study demonstrates that the tested CaS/HA material combined with BMP-2 could replace autologous bone harvesting in spinal fusion surgery. Addition of TOB could potentially protect the material from bacterial colonization during the early post-operative period but further studies in infection models are warranted.
- 1 March 2026
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 17 (3) , 118
Open AccessA Pre-Set Calcium Sulfate/Hydroxyapatite Biomaterial as an Antibiotic-Eluting Bone Extender and a Carrier for BMP-2: A Pilot Study in a Rabbit Posterolateral Spinal Fusion Model
Synthetic biomaterials used as bone graft extenders (BGE) in spinal fusion surgery can supplement but do not replace autologous bone. This pilot study evaluated a calcium sulfate/hydroxyapatite (CaS/HA) material as an antibiotic-eluting BGE and a carrier for bone morphogenetic protein-2 (BMP-2) in a rabbit posterolateral lumbar (L4–L5) spinal fusion model (PLF). Pre-set CaS/HA beads were loaded with tobramycin (TOB) and tested for in vitro antibiotic release and antibacterial activity against Staphylococcus aureus. For the in vivo PLF study, CaS/HA beads were used in two treatment strategies: (1) CaS/HA + TOB + autograft (left side) and (2) CaS/HA + BMP-2 (right side). Serum levels of TOB were quantified and spinal fusion was evaluated after 12 weeks. TOB exhibited a rapid initial release, followed by a decline below detectable levels after 6 h in vitro and 48 h in vivo. TOB-loaded CaS/HA beads demonstrated in vitro antibacterial activity for 19 days. In the PLF study, 5/6 and 6/6 specimens were fused radiologically in the TOB and BMP groups, respectively, and 100% using mechanical testing. Micro-CT analysis showed no significant difference in bone volume between the TOB and BMP-2 groups (364 ± 84 vs. 479 ± 95 mm3). Histology verified continuous bone bridging in both groups. Our in vitro findings indicate that locally added TOB could protect the CaS/HA material from bacterial colonization and did not adversely impact the CaS/HA material negatively to act as BGE. The addition of low-dose BMP-2 to the CaS/HA material proved effective in building bone without the need to harvest autologous bone. In summary, this pilot PLF study demonstrates that the tested CaS/HA material combined with BMP-2 could replace autologous bone harvesting in spinal fusion surgery. Addition of TOB could potentially protect the material from bacterial colonization during the early post-operative period but further studies in infection models are warranted.
- Open Access
- 14 January 2026
- Published by Elsevier in Arthroplasty Today
- Vol. 37, 101943
Managing Knee Arthrodesis Conversion to Arthroplasty in a Young Patient: Surgical Strategy, Challenges, and Functional Recovery After 1 Year
- 14 January 2026
- Published by Elsevier in Arthroplasty Today
- Vol. 37, 101943
Open AccessManaging Knee Arthrodesis Conversion to Arthroplasty in a Young Patient: Surgical Strategy, Challenges, and Functional Recovery After 1 Year